Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells

References

• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241 - 52; http://dx.doi.org/10.1056/NEJMra035010; PMID: 14657432
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10 - 30; http://dx.doi.org/10.3322/canjclin.55.1.10; PMID: 15661684
   PubMed Web of Science ®Google Scholar
• Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, et al. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis 2008; 29:307 - 15; http://dx.doi.org/10.1093/carcin/bgm269; PMID: 18048386
   PubMed Web of Science ®Google Scholar
• Kim JY, Do YR, Park KU, Kim MK, Lee KH, Bae SH, et al. A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer. Cancer Chemother Pharmacol 2010; 66:31 - 6; http://dx.doi.org/10.1007/s00280-009-1130-6; PMID: 19763571
   PubMed Web of Science ®Google Scholar
• Kantari C, Walczak H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta 2011; 1813:558 - 63; http://dx.doi.org/10.1016/j.bbamcr.2011.01.026; PMID: 21295084
   PubMed Web of Science ®Google Scholar
• Tsai WS, Yeow WS, Chua A, Reddy RM, Nguyen DM, Schrump DS, et al. Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin. Mol Cancer Ther 2006; 5:2977 - 90; http://dx.doi.org/10.1158/1535-7163.MCT-05-0514; PMID: 17172403
   PubMed Web of Science ®Google Scholar
• Borgne A, Versteege I, Mahé M, Studeny A, Léonce S, Naime I, et al. Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. Oncogene 2006; 25:7361 - 72; http://dx.doi.org/10.1038/sj.onc.1209718; PMID: 16785996
   PubMed Web of Science ®Google Scholar
• Jun DY, Kim JS, Park HS, Song WS, Bae YS, Kim YH. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells. Toxicol Appl Pharmacol 2007; 222:190 - 201; http://dx.doi.org/10.1016/j.taap.2007.04.011; PMID: 17559898
   PubMed Web of Science ®Google Scholar
• Tommasi S, Besaratinia A, Wilczynski SP, Pfeifer GP. Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy. Oncogene 2011; 30:690 - 700; http://dx.doi.org/10.1038/onc.2010.440; PMID: 20890300
   PubMed Web of Science ®Google Scholar
• Chang E, Donahue J, Smith A, Hornick J, Rao JN, Wang JY, et al. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. J Thorac Cardiovasc Surg 2010; 140:225 - 32; http://dx.doi.org/10.1016/j.jtcvs.2009.11.038; PMID: 20236666
   PubMed Web of Science ®Google Scholar
• Lubin DJ, Butler JS, Loh SN. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function. J Mol Biol 2010; 395:705 - 16; http://dx.doi.org/10.1016/j.jmb.2009.11.013; PMID: 19913028
   PubMed Web of Science ®Google Scholar
• Li K, He W, Lin N, Wang X, Fan QX. Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma. Cancer Invest 2010; 28:479 - 86; http://dx.doi.org/10.3109/07357900903476745; PMID: 20014942
   PubMed Web of Science ®Google Scholar
• Wang X, Dong L, Xie J, Tong T, Zhan Q. Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis. Cancer Biol Ther 2009; 8:1852 - 9; http://dx.doi.org/10.4161/cbt.8.19.9550; PMID: 19770595
   PubMed Web of Science ®Google Scholar
• Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 1998; 141:875 - 85; http://dx.doi.org/10.1083/jcb.141.4.875; PMID: 9585407
   PubMed Web of Science ®Google Scholar
• Tang L, Zhang Y, Pan H, Luo Q, Zhu XM, Dong MY, et al. Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest, and apoptosis in human endometrial cell. Reprod Biol Endocrinol 2009; 7:144; http://dx.doi.org/10.1186/1477-7827-7-144; PMID: 19968870
   PubMed Web of Science ®Google Scholar
• Yuan J, Yan R, Krämer A, Eckerdt F, Roller M, Kaufmann M, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004; 23:5843 - 52; http://dx.doi.org/10.1038/sj.onc.1207757; PMID: 15208674
   PubMed Web of Science ®Google Scholar
• Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 2002; 62:6414 - 7; PMID: 12438226
   PubMed Web of Science ®Google Scholar
• Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997; 57:4736 - 8; PMID: 9354433
   PubMed Web of Science ®Google Scholar
• Risinger JI, Hayes K, Maxwell GL, Carney ME, Dodge RK, Barrett JC, et al. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res 1998; 4:3005 - 10; PMID: 9865913
   PubMed Web of Science ®Google Scholar
• Marsh DJ, Dahia PL, Caron S, Kum JB, Frayling IM, Tomlinson IP, et al. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 1998; 35:881 - 5; http://dx.doi.org/10.1136/jmg.35.11.881; PMID: 9832031
   PubMed Web of Science ®Google Scholar
• Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254:274 - 7; http://dx.doi.org/10.1126/science.1833819; PMID: 1833819
   PubMed Web of Science ®Google Scholar
• Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, et al. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 2000; 60:5988 - 94; PMID: 11085518
   PubMed Web of Science ®Google Scholar
• Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998; 279:710 - 4; http://dx.doi.org/10.1126/science.279.5351.710; PMID: 9445477
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489 - 501; http://dx.doi.org/10.1038/nrc839; PMID: 12094235
   PubMed Web of Science ®Google Scholar
• McDonnell MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A. Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells. Cell Death Differ 2003; 10:1005 - 15; http://dx.doi.org/10.1038/sj.cdd.4401271; PMID: 12934075
   PubMed Web of Science ®Google Scholar
• Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941 - 53; PMID: 10561374
   PubMed Web of Science ®Google Scholar
• Wan X, Helman LJ. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene 2003; 22:8205 - 11; http://dx.doi.org/10.1038/sj.onc.1206878; PMID: 14603261
   PubMed Web of Science ®Google Scholar
• Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96:4240 - 5; http://dx.doi.org/10.1073/pnas.96.8.4240; PMID: 10200246
   PubMed Web of Science ®Google Scholar
• Chae HD, Broxmeyer HE. SIRT1 Deficiency Downregulates PTEN/JNK/FOXO1 Pathway to Block ROS-Induced Apoptosis in Mouse Embryonic Stem Cells. Stem Cells Dev 2011; 20:1277 - 85; http://dx.doi.org/10.1089/scd.2010.0465; PMID: 21083429
   PubMed Web of Science ®Google Scholar
• Li HF, Keeton A, Vitolo M, Maddox C, Rasmussen L, Hobrath J, et al. A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells. J Biomol Screen 2011; 16:383 - 93; http://dx.doi.org/10.1177/1087057110397357; PMID: 21335596
   PubMed Web of Science ®Google Scholar
• Yamada K, Kunishima N, Mayanagi K, Ohnishi T, Nishino T, Iwasaki H, et al. Crystal structure of the Holliday junction migration motor protein RuvB from Thermus thermophilus HB8. Proc Natl Acad Sci USA 2001; 98:1442 - 7; http://dx.doi.org/10.1073/pnas.98.4.1442; PMID: 11171970
   PubMed Web of Science ®Google Scholar
• Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 2002; 94:3127 - 34; http://dx.doi.org/10.1002/cncr.10591; PMID: 12115344
   PubMed Web of Science ®Google Scholar
• Xie XH, An HJ, Kang S, Hong S, Choi YP, Kim YT, et al. Loss of Cyclin B1 followed by downregulation of Cyclin A/Cdk2, apoptosis and antiproliferation in Hela cell line. Int J Cancer 2005; 116:520 - 5; http://dx.doi.org/10.1002/ijc.21056; PMID: 15818617
   PubMed Web of Science ®Google Scholar
• Yuan J, Krämer A, Matthess Y, Yan R, Spänkuch B, Gätje R, et al. Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene 2006; 25:1753 - 62; http://dx.doi.org/10.1038/sj.onc.1209202; PMID: 16278675
   PubMed Web of Science ®Google Scholar
• Gomez LA, de Las Pozas A, Reiner T, Burnstein K, Perez-Stable C. Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy. Mol Cancer Ther 2007; 6:1534 - 43; http://dx.doi.org/10.1158/1535-7163.MCT-06-0727; PMID: 17513602
   PubMed Web of Science ®Google Scholar
• Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94:491 - 501; http://dx.doi.org/10.1016/S0092-8674(00)81590-1; PMID: 9727492
   PubMed Web of Science ®Google Scholar
• Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144:281 - 92; http://dx.doi.org/10.1083/jcb.144.2.281; PMID: 9922454
   PubMed Web of Science ®Google Scholar
• Kumar N. Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 1981; 256:10435 - 41; PMID: 6116707
   PubMed Web of Science ®Google Scholar
• Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277:665 - 7; http://dx.doi.org/10.1038/277665a0; PMID: 423966
   PubMed Web of Science ®Google Scholar
• Horwitz SB. Mechanism of action of taxol. Trends Pharmacol Sci 1992; 13:134 - 6; http://dx.doi.org/10.1016/0165-6147(92)90048-B; PMID: 1350385
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56:816 - 25; PMID: 8631019
   PubMed Web of Science ®Google Scholar
• Szymkowski DE, Yarema K, Essigmann JM, Lippard SJ, Wood RD. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc Natl Acad Sci USA 1992; 89:10772 - 6; http://dx.doi.org/10.1073/pnas.89.22.10772; PMID: 1438274
   PubMed Web of Science ®Google Scholar
• Akca H, Demiray A, Tokgun O, Yokota J. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells. Lung Cancer 2011; 73:302 - 9; http://dx.doi.org/10.1016/j.lungcan.2011.01.012; PMID: 21333374
   PubMed Web of Science ®Google Scholar
• Wang T, Lv JH, Zhang XF, Li CJ, Han X, Sun YJ. Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1. Int J Cancer 2010; 126:362 - 70; http://dx.doi.org/10.1002/ijc.24753; PMID: 19609944
   PubMed Web of Science ®Google Scholar
• Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 1999; 59:2551 - 6; PMID: 10363971
   PubMed Web of Science ®Google Scholar
• Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, et al. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 2004; 23:5853 - 7; http://dx.doi.org/10.1038/sj.onc.1207721; PMID: 15208673
   PubMed Web of Science ®Google Scholar
• Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943 - 7; http://dx.doi.org/10.1126/science.275.5308.1943; PMID: 9072974
   PubMed Web of Science ®Google Scholar
• Han Y, Wei F, Xu X, Cai Y, Chen B, Wang J, et al. [Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19:455 - 7; PMID: 12476413
   PubMedGoogle Scholar
• Miyahara T, Ueda K, Akaboshi M, Shimada Y, Imamura M, Utsumi H. Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diamminedichloroplatinum(II) in cultured human esophageal cancer cells. Jpn J Cancer Res 1993; 84:336 - 40; http://dx.doi.org/10.1111/j.1349-7006.1993.tb02875.x; PMID: 8486532
   PubMedGoogle Scholar